首页 > 市场调查报告书 > 製药

呼吸器

市场调查报告书

商品编码

1578236

全球气喘治疗市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Asthma Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年09月01日 | 出版商:

Value Market Research | 英文 132 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球气喘治疗市场需求预计将从 2023 年的 320.8 亿美元达到 2032 年近 534.7 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 5.84%。

气喘通常是由室内和室外因素引起的，例如污染、过敏原和灰尘。气喘治疗是指一类用于治疗气喘的药物。这些药物通常是支气管扩张剂和抗发炎剂。这些药物可以拓宽进入肺部的通道，促进空气流通，进而改善呼吸。它们还有助于清除肺部的黏液，这些黏液很容易咳出。

市场动态

气喘治疗市场可能在未来几年逐渐扩大。呼吸系统疾病发生率的上升可能会推动全球气喘治疗市场的成长。气喘是一种进行性呼吸系统疾病，可能致命。因此，呼吸系统疾病患者数量的不断增加支持了全球气喘治疗市场的扩张。此外，吸烟者人数的增加、可支配收入的增加、对气喘早期诊断优势的了解的增加以及对改善医疗设施的需求的增加可能会推动气喘治疗市场的发展。由于技术先进的产品和对这些条件的认识水平不断提高，预计该市场将会发展。气喘治疗生物製剂领域不断涌现的研究被视为市场最有前景的前景。对抑制免疫球蛋白 E 和特定细胞激素的单株抗体也有很高的需求。另一个促进生长的因素是开发这些治疗呼吸系统疾病的联合疗法。然而，药品专利到期数量不断增加、仿製药使用量增加以及气喘治疗成本高昂是限制全球气喘治疗市场成长的主要因素。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球气喘治疗市场的每个细分市场进行了包容性评估。气喘治疗产业的成长和趋势为本研究提供了整体方法。

市场区隔

气喘治疗市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按药物类别

消炎剂
支气管扩张剂
联合疗法

按产品分类

吸入器（干粉、定量、软雾）
雾化器

依给药途径

口服
吸入
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲气喘治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。气喘治疗市场的主要参与者包括Teva Pharmaceutical Industries Ltd.、GSK Plc、Merck & Co. Inc.、F. Hoffmann-La Roche Ltd、阿斯特捷利康、勃林格殷格翰国际有限公司、赛诺菲、Koninklijke Philips NV、BD、Covis製药。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：气喘治疗公司的竞争格局

气喘治疗市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
Teva Pharmaceutical Industries Ltd.

公司概况
公司收入
产品
最新动态

GSK Plc

公司概况
公司收入
产品
最新动态

Merck & Co. Inc.

公司概况
公司收入
产品
最新动态

F. Hoffmann-La Roche Ltd

公司概况
公司收入
产品
最新动态

AstraZeneca

公司概况
公司收入
产品
最新动态

Boehringer Ingelheim International GmbH

公司概况
公司收入
产品
最新动态

Sanofi.

公司概况
公司收入
产品
最新动态

Koninklijke Philips NV

公司概况
公司收入
产品
最新动态

公司概况
公司收入
产品
最新动态

Covis Pharma

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11217451

The global demand for Asthma Therapeutics Market is presumed to reach the market size of nearly USD 53.47 Billion by 2032 from USD 32.08 Billion in 2023 with a CAGR of 5.84% under the study period 2024-2032.

Asthma is typically caused by indoor and outdoor factors such as pollution, allergens, and dust. Asthma therapeutics refers to a class of pharmacological medications used to treat asthma. These medications are often bronchodilators and anti-inflammatory agents. These medications widen the pathway into the lungs and allow for the flow of air, which improves breathing. They also help remove mucus from the lungs, which is easily coughed out.

MARKET DYNAMICS

The asthma therapeutics market is likely to expand gradually in the coming years. The rising incidence of respiratory disorders is likely to fuel worldwide asthma treatments market growth. Asthma is a progressive respiratory condition that can be fatal. As a result, the growing number of respiratory illness patients supports the expansion of the worldwide asthma therapeutics market. Also, an expanding population of smokers, an increase in disposable income, increased knowledge about the advantages of earlier diagnosis of asthma, and increased demand for improved healthcare facilities are likely to boost the asthma treatment market. The market is expected to develop due to technologically sophisticated goods and growing awareness levels regarding these conditions. Rising research in the realm of biologics for asthma therapy is viewed as the market's most promising prospect. There is also a high need for monoclonal antibodies that inhibit immunoglobulin E and particular cytokines. Another growth-promoting factor is the development of these combination treatments to treat respiratory disorders. However, the rising number of medication patent expirations, the increased usage of generic pharmaceuticals, and the high cost of asthma treatment are primary factors constraining the worldwide asthma therapeutics market's growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Asthma Therapeutics. The growth and trends of Asthma Therapeutics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Asthma Therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Class

Anti- Inflammatory
Bronchodilators
Combination Therapy

By Product

Inhalers (Dry Powder, Metered Dose, Soft Mist)
Nebulizers

By Route of Administration

Oral
Inhaled
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Asthma Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Asthma Therapeutics market include Teva Pharmaceutical Industries Ltd., GSK Plc, Merck & Co. Inc., F. Hoffmann-La Roche Ltd, AstraZeneca, Boehringer Ingelheim International GmbH, Sanofi., Koninklijke Philips N.V., BD, Covis Pharma. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ASTHMA THERAPEUTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Drug Class
- 3.7.2 Market Attractiveness Analysis By Product
- 3.7.3 Market Attractiveness Analysis By Route of Administration
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS

5.1. Overview By Drug Class
5.2. Historical and Forecast Data Analysis By Drug Class
5.3. Anti- Inflammatory Historic and Forecast Sales By Regions
5.4. Bronchodilators Historic and Forecast Sales By Regions
5.5. Combination Therapy Historic and Forecast Sales By Regions

6. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY PRODUCT

6.1. Overview By Product
6.2. Historical and Forecast Data Analysis By Product
6.3. Inhalers (Dry Powder, Metered Dose, Soft Mist) Historic and Forecast Sales By Regions
6.4. Nebulizers Historic and Forecast Sales By Regions

7. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

7.1. Overview By Route of Administration
7.2. Historical and Forecast Data Analysis By Route of Administration
7.3. Oral Historic and Forecast Sales By Regions
7.4. Inhaled Historic and Forecast Sales By Regions
7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ASTHMA THERAPEUTICS COMPANIES

9.1. Asthma Therapeutics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF ASTHMA THERAPEUTICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Teva Pharmaceutical Industries Ltd.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. GSK Plc
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Merck & Co. Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. F. Hoffmann-La Roche Ltd
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. AstraZeneca
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Boehringer Ingelheim International GmbH
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Sanofi.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Koninklijke Philips N.V.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. BD
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Covis Pharma
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Drug Class (USD MN)
Anti- Inflammatory Market Sales By Geography (USD MN)
Bronchodilators Market Sales By Geography (USD MN)
Combination Therapy Market Sales By Geography (USD MN)
Analysis By Product (USD MN)
Inhalers (Dry Powder, Metered Dose, Soft Mist) Market Sales By Geography (USD MN)
Nebulizers Market Sales By Geography (USD MN)
Analysis By Route of Administration (USD MN)
Oral Market Sales By Geography (USD MN)
Inhaled Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Asthma Therapeutics Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Asthma Therapeutics Report
Market Research Process
Market Research Methodology
Global Asthma Therapeutics Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Drug Class
Market Attractiveness Analysis By Product
Market Attractiveness Analysis By Route of Administration
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Drug Class (USD MN)
Anti- Inflammatory Market Sales By Geography (USD MN)
Bronchodilators Market Sales By Geography (USD MN)
Combination Therapy Market Sales By Geography (USD MN)
Global Market Analysis By Product (USD MN)
Inhalers (Dry Powder, Metered Dose, Soft Mist) Market Sales By Geography (USD MN)
Nebulizers Market Sales By Geography (USD MN)
Global Market Analysis By Route of Administration (USD MN)
Oral Market Sales By Geography (USD MN)
Inhaled Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis